SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950123-10-042424
Filing Date
2010-05-03
Accepted
2010-05-03 09:46:57
Documents
8
Period of Report
2010-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q a55972e10vq.htm 10-Q 363286
2 EX-10.1 a55972exv10w1.htm EX-10.1 27388
3 EX-10.2 a55972exv10w2.htm EX-10.2 163472
4 EX-31.1 a55972exv31w1.htm EX-31.1 6737
5 EX-31.2 a55972exv31w2.htm EX-31.2 7038
6 EX-32.1 a55972exv32w1.htm EX-32.1 3694
7 GRAPHIC a55972a5597200.gif GRAPHIC 3162
8 GRAPHIC a55972a5597201.gif GRAPHIC 4545
  Complete submission text file 0000950123-10-042424.txt   584161
Mailing Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656
Business Address 101 ENTERPRISE SUITE 300 ALISO VIEJO CA 92656 949-389-6700
AVANIR PHARMACEUTICALS, INC. (Filer) CIK: 0000858803 (see all company filings)

IRS No.: 330314804 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-15803 | Film No.: 10789915
SIC: 2834 Pharmaceutical Preparations